Le Lézard
Classified in: Health, Covid-19 virus
Subject: PER

Dr. Michael Anderson joins Aveshka as Pediatric Science Consultant in support of ASPR COVID-19 disaster relief initiatives


WASHINGTON, Oct. 20, 2020 /PRNewswire/ -- Dr. Michael Anderson joins Aveshka as full-time consultant to provide support from a pediatric perspective to the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR).

Dr. Anderson has been supporting ASPR since March 2020, specifically pertaining to the new initiatives that have resulted from COVID-19. His pediatric expertise sheds light on the overall impact the pandemic has had on children, including emotional, social and developmental effects, the impact on children with special healthcare needs, and the increase of secondary diseases in children (such as Multisystem Inflammatory Syndrome).

"Dr. Anderson will be, without a doubt, a critical contributor to Aveshka's work in public health and emergency management, especially in advising our customers in responding to the COVID-19 pandemic," said Andrew Weis, Aveshka Senior Vice President, Growth & Operations. "His pediatric expertise brings a niche capability to Aveshka and contributes to our goal of continuous improvement and expansion of services for our customers."

As a highly acclaimed pediatric critical care specialist, Professor of Pediatrics and Children's Hospital leader, Dr. Anderson has published and presented on pediatric topics including safety/high reliability, pediatric disaster preparedness, and physician workforce. Prior to joining Aveshka, he served as President and SVP, Children Care of UCSF Benioff Children's Hospital and as Chief Medical Officer for University Hospitals in Cleveland Ohio. Previously, as President George W. Bush's appointee, he served as Vice Chair of the National Commission on Children and Disasters. In 2014, Dr. Anderson was appointed by the Obama Administration to chair the National Advisory Committee on Children and Disasters at HHS.

As a pediatric science consultant with Aveshka, Dr. Anderson will continue to work with ASPR's medical and public health professionals to address immediate concerns and mitigate the long-term, adverse consequences of the pandemic on the younger generation.

"It is truly an honor to work for Aveshka and to assist our colleagues at HHS/ASPR in addressing the unique needs of children affected by COVID 19. While children have not been hospitalized in large numbers with acute COVID (thank goodness) we know the pandemic is taking a serious toll on our Nation's Children and we must rally to support them!"

ABOUT AVESHKA, INC.
Aveshka is a thought leader that integrates strategy, technology and innovation to deliver cutting edge, breakthrough solutions that strengthen the nation against security threats. Aveshka accelerates the advantage for its customers' missions, rendering them protected today and prepared for a safer and smarter tomorrow. Visit www.aveshka.com.

SOURCE Aveshka, Inc.


These press releases may also interest you

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

18 avr 2024
Banco Latinoamericano de Comercio Exterior, S.A. , a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced...



News published on and distributed by: